1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Gi-Byoung Nam: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease Edoxaban Monotherapy, Edoxaban plus Single Antiplatelet Agent - Atrial Fibrillation, Coronary Artery Disease | Phase 4 | Completed | Gi-Byoung Nam | 1040 | 2019-05-14 | 2024-06-10 |
Angina, Stable (1) · Atrial Fibrillation (1) · Coronary Artery Disease (1)
Platelet Aggregation Inhibitors (1) · edoxaban (1)
South Korea (1)
Duk-woo Park, MD (1)
PMID 39225258, PMID 40930594, PMID 41762182, PMID 41848064, PMID 42003300, PMID 42690164